Kardiologie up2date 2008; 4(4): 276-280
DOI: 10.1055/s-0028-1103447
Hotline – Angeborene und erworbene Herzfehler

© Georg Thieme Verlag KG Stuttgart · New York

Bioengineering von Herzklappen

Markus  Krane, Sara  Dummler, Martina  Dressen, Robert  Bauernschmitt, Rüdiger  Lange
Further Information

Publication History

Publication Date:
30 December 2008 (online)

Abstract

Clinically used valve prostheses are still associated with several limitations. The biological prostheses are limited due to their durability and mechanical valves need permanent oral anticoagulation. Tissue engineering could become a capable tool to create an „ideal” living heart valve with the potential to grow. This would be a matter of particular interest especially in paediatric patients. This article gives a short overview about current concepts, used cell types and clinical experiences with tissue engineered heart valves.

Literatur

  • 1 Gummert J F, Funkat A, Beckmann A. et al . Cardiac surgery in Germany during 2006: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery.  The Thoracic and cardiovascular surgeon. 2007;  55 343-350
  • 2 Hoerstrup S P, Sodian R, Daebritz S. et al . Functional living trileaflet heart valves grown in vitro.  Circulation. 2000;  102 III-44-III-49
  • 3 Hilbert S L, Yanagida R, Souza J. et al . Prototype anionic detergent technique used to decellularize allograft valve conduits evaluated in the right ventricular outflow tract in sheep.  The Journal of heart valve disease. 2004;  13 831-840
  • 4 Mendelson K, Schoen F J. Heart valve tissue engineering: concepts, approaches, progress, and challenges.  Annals of biomedical engineering. 2006;  34 1799-1819
  • 5 Schmidt D, Mol A, Breymann C. et al . Living autologous heart valves engineered from human prenatally harvested progenitors.  Circulation. 2006;  114 I125-131
  • 6 Sutherland F W, Perry T E, Sherwood M C. et al . From stem cells to viable autologous semilunar heart valve.  Circulation. 2005;  111 2783-2791
  • 7 Teebken O E, Wilhelmi M, Haverich A. Tissue engineering for heart valves and vascular grafts.  Der Chirurg. 2005;  76 453-466
  • 8 Rabkin-Aikawa E, Farber M, Aikawa M, Schoen F J. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves.  The Journal of heart valve disease. 2004;  13 841-847
  • 9 Schmidt D, Hoerstrup S P. Tissue engineered heart valves based on human cells.  Swiss Med Wkly. 2006;  136 618-623
  • 10 Schnell A M, Hoerstrup S P, Zund G. et al . Optimal cell source for cardiovascular tissue engineering: venous vs. aortic human myofibroblasts.  The Thoracic and cardiovascular surgeon. 2001;  49 221-225
  • 11 Schmidt D, Mol A, Odermatt B. et al . Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells.  Tissue engineering. 2006;  12 3223-3232
  • 12 Hoerstrup S P, Kadner A, Melnitchouk S. et al . Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.  Circulation. 2002;  106 I143-150
  • 13 Perry T E, Kaushal S, Sutherland F WH. et al . Bone marrow as a cell source for tissue engineering heart valves.  Ann Thorac Surg. 2003;  75 761-767
  • 14 Schmidt D, Achermann J, Odermatt B. et al . Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.  Circulation. 2007;  116 I64-I70
  • 15 Shinoka T, Ma P X, Shum-Tim D. et al . Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model.  Circulation. 1996;  94 II-164-II-168
  • 16 Sodian R, Hoerstrup S P, Sperling J S. et al . Early in vivo experience with tissue-engineered trileaflet heart valves.  Circulation. 2000;  102 III-22-III-29
  • 17 Steinhoff G, Stock U, Karim N. et al . Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue.  Circulation. 2000;  102 III-50-III-55
  • 18 Elkins R C, Dawson P E, Goldstein S, Walsh S P, Black K S. Decellularized human valve allografts.  Ann Thorac Surg. 2001;  71 S428-S432
  • 19 Dohmen P M, Lembcke A, Holinski S. et al . Mid-term clinical results using a tissue-engineered pulmonary valve to reconstruct the right ventricular outflow tract during the Ross procedure.  Ann Thorac Surg. 2007;  84 729-736
  • 20 Dohmen P M, Lembcke A, Hotz H, Kivelitz D, Konertz W. Ross Operation With a Tissue-Engineered Heart Valve.  Ann Thorac Surg. 2002;  74 1438-1442
  • 21 Simon P, Kasimir M T, Seebacher G. et al . Early failure of the tissue engineered porcine haert valve SYNERGRAFT in pediatric patients.  Eur J Cardiothorac Surg. 2003;  23 1002-1006

Dr. med. Markus Krane

Deutsches Herzzentrum München
Klinik für Herz- und Gefäßchirurgie

Lazarettstr. 36
80636 München

Email: krane@dhm.mhn.de

    >